PRME
Prime Medicine, Inc. · Healthcare
10% owner Gv 2019 Gp, L.L.C. sold $1.1M of Prime Medicine, Inc.
Sold$1,092,435
$14.93Price
73,191Shares
−1%Stake
What PRME did after the filing
- The stock from Tue, Jun 20 close, $15.20
- −7.7%
- S&P 500, same days
- +3.0%
Measured over 30 trading days, to the Aug 2 close.
Traded Thu, Jun 15. Filed Tue, Jun 20, 12:17 PM ET, during the session. Returns use the Jun 20 close and the Aug 2 close. Not investment advice.